RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.

Imposing higher capital requirements on UBS as a systemically relevant bank will usher in higher costs for companies and ...

RBC Capital analyst Nik Modi maintained a Hold rating on Energizer Holdings (ENR – Research Report) today and set a price target of $38.00. The ...

UBS implements Azure-based assistant to 30,000 staff in Asian and European booking centres through enterprise-scale ...

DGS Capital Management LLC grew its stake in shares of JPMorgan Chase & Co. (NYSE:JPM) by 5.0% in the fourth quarter, ...

UBS analyst Susy Tibaldi updated the financial outlook for EssilorLuxottica SA (EL:FP) (OTC: OTC:ESLOY), increasing the price ...

Prologis (NYSE:PLD – Get Free Report) had its price target raised by UBS Group from $121.00 to $137.00 in a research report ...

Bonnici was a managing director at RBC and led several high-profile deals across infrastructure and technology during his ...

Q4 2024 Earnings Conference Call January 29, 2025 11:00 AM ETCompany ParticipantsJeremy Ulan – Head-Investor Relations ...

In the assessment of 12-month price targets, analysts unveil insights for Gilead Sciences, presenting an average target of ...

Financial markets are near certain that the Reserve Bank will cut interest rates in February, after the latest CPI data ...

MSC Income Fund, Inc. ("MSC Income" or the "Company"), an externally managed business development company, today announced that it priced its public offering of 5,500,000 shares of its common stock ...